Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) by 20.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,201 shares of the company's stock after purchasing an additional 2,774 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in The Ensign Group were worth $2,152,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of ENSG. AlphaQuest LLC increased its stake in The Ensign Group by 754.8% during the 4th quarter. AlphaQuest LLC now owns 3,026 shares of the company's stock worth $402,000 after buying an additional 2,672 shares in the last quarter. Edgestream Partners L.P. increased its stake in The Ensign Group by 23.0% during the 4th quarter. Edgestream Partners L.P. now owns 46,721 shares of the company's stock worth $6,207,000 after buying an additional 8,744 shares in the last quarter. Candriam S.C.A. acquired a new position in shares of The Ensign Group during the 4th quarter worth approximately $3,702,000. Inceptionr LLC boosted its holdings in shares of The Ensign Group by 81.5% during the 4th quarter. Inceptionr LLC now owns 14,258 shares of the company's stock worth $1,894,000 after purchasing an additional 6,401 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in The Ensign Group in the fourth quarter valued at approximately $36,167,000. Hedge funds and other institutional investors own 96.12% of the company's stock.
Insider Transactions at The Ensign Group
In other The Ensign Group news, Director Daren Shaw sold 2,000 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $129.66, for a total value of $259,320.00. Following the completion of the transaction, the director now directly owns 26,325 shares of the company's stock, valued at approximately $3,413,299.50. This trade represents a 7.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Barry M. Smith sold 700 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $133.43, for a total transaction of $93,401.00. Following the completion of the transaction, the director now directly owns 30,852 shares of the company's stock, valued at approximately $4,116,582.36. This trade represents a 2.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 43,186 shares of company stock worth $6,345,115. Company insiders own 3.90% of the company's stock.
The Ensign Group Stock Performance
Shares of ENSG stock traded down $1.20 during mid-day trading on Thursday, hitting $129.59. 340,540 shares of the stock were exchanged, compared to its average volume of 387,271. The stock's fifty day simple moving average is $132.98 and its two-hundred day simple moving average is $141.11. The stock has a market capitalization of $7.45 billion, a price-to-earnings ratio of 25.36, a P/E/G ratio of 1.52 and a beta of 0.98. The Ensign Group, Inc. has a 12-month low of $113.27 and a 12-month high of $158.45. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.56 and a current ratio of 1.56.
The Ensign Group (NASDAQ:ENSG - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.11). The Ensign Group had a return on equity of 17.07% and a net margin of 6.99%. On average, analysts forecast that The Ensign Group, Inc. will post 5.59 EPS for the current year.
Analyst Ratings Changes
A number of research firms have commented on ENSG. Macquarie upped their price target on The Ensign Group from $165.00 to $166.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 4th. Truist Financial dropped their target price on The Ensign Group from $170.00 to $155.00 and set a "hold" rating on the stock in a report on Monday, January 6th. Stephens reissued an "overweight" rating and issued a $155.00 target price on shares of The Ensign Group in a report on Thursday, February 6th. Finally, UBS Group initiated coverage on The Ensign Group in a report on Thursday, November 21st. They issued a "buy" rating and a $175.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, The Ensign Group has a consensus rating of "Moderate Buy" and a consensus price target of $165.17.
Check Out Our Latest Stock Analysis on ENSG
The Ensign Group Profile
(
Free Report)
The Ensign Group, Inc provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services.
Featured Articles

Before you consider The Ensign Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Ensign Group wasn't on the list.
While The Ensign Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.